BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/22/2021 8:36:46 AM | Browse: 583 | Download: 1567
 |
Received |
|
2020-12-24 14:01 |
 |
Peer-Review Started |
|
2020-12-25 00:23 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2021-01-11 03:39 |
 |
Revised |
|
2021-01-19 19:24 |
 |
Second Decision |
|
2021-02-03 09:53 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2021-02-12 05:13 |
 |
Articles in Press |
|
2021-02-12 05:13 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2021-02-23 22:44 |
 |
Typeset the Manuscript |
|
2021-03-19 01:27 |
 |
Publish the Manuscript Online |
|
2021-03-22 08:36 |
ISSN |
1949-8462 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Cardiac & Cardiovascular Systems |
Manuscript Type |
Prospective Study |
Article Title |
Elevated interleukin-6 levels are associated with impaired outcome in cardiac ATTR amyloidosis
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Selina J Hein, Maximilian Knoll, Fabian Aus dem Siepen, Jennifer Furkel, Stefan Schoenland, Ute Hegenbart, Hugo A Katus, Arnt V Kristen and Mathias Konstandin |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Alnylam Pharmaceuticals® |
PO 4510001138 |
German Research Foundation and German Center for Cardiovascular Research Funding |
KO-3900 |
|
Corresponding Author |
Selina J Hein, MD, Consultant Physician-Scientist, Postdoc, Department of Cardiology, Pneumology and Angiology, University Hospital Heidelberg, INF 410, Heidelberg 69120, BW, Germany. selina.hein@med.uni-heidelberg.de |
Key Words |
Transthyretin amyloidosis; Inflammation; Heart failure; Interleukin-6; Outcome; Risk stratification |
Core Tip |
This was a monocentric prospective trial with 106 patients suffering from transthyretin cardiomyopathy (ATTR-CM) seeking to evaluate the prognostic value of interleukin (IL)-6 in ATTR-CM. IL-6 is associated with outcome in ATTR-CM but did not further ameliorate existing risk prediction models. |
Publish Date |
2021-03-22 08:36 |
Citation |
Hein SJ, Knoll M, Siepen FAD, Furkel J, Schoenland S, Hegenbart U, Katus HA, Kristen AV, Konstandin M. Elevated interleukin-6 levels are associated with impaired outcome in cardiac ATTR amyloidosis. World J Cardiol 2021; 13(3): 55-67 |
URL |
https://www.wjgnet.com/1949-8462/full/v13/i3/55.htm |
DOI |
https://dx.doi.org/10.4330/wjc.v13.i3.55 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345